38 results on '"Tafuri, Giovanni"'
Search Results
2. SURVEY ON THE IMPACT OF ARTIFICIAL INTELLIGENCE IN EDUCATION AND SCHOOLS.
3. Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations
4. Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
5. STUDY ON THE EFFECTIVENESS OF THE TEACHING OFFER OF THE SECONDARY SCHOOL IN PREPARATION FOR THE WORLD OF WORK.
6. Social Educational Models to enhance the culture of different abilities: Disability Management
7. The role of sport to foster an inclusive socio-multicultural system
8. HEALING CLASSROOMS: ANALYSIS OF SPECIAL PEDAGOGY PROCESSES TO ADDRESS SOCIAL TRAUMA, OPPRESSION AND DISABILITY FROM THE PERSPECTIVE OF INCLUSIVE LEARNING.
9. THE ROLE OF MOTOR-SPORTS DIDACTICS IN PRIMARY SCHOOL: THE TEACHER'S PERSPECTIVE.
10. Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014–2019
11. Access and pricing of medicines for patients with rare diseases in the European Union: an industry perspective
12. Off-label use of medicines in children: can available evidence avoid useless paediatric trials?: The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease
13. Access and pricing of medicines for patients with rare diseases in the European Union: an industry perspective.
14. Haematological anticancer drugs in Europe: any added value at the time of approval?
15. Disclosure of grounds of European withdrawn and refused applications: a step forward on regulatory transparency
16. The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes
17. How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?
18. Using GRADE methodology to assess innovation of new medicinal products in Italy
19. Current state of quality of life and patient-reported outcomes research
20. The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations
21. How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?
22. In reply to: Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children
23. How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?
24. Using GRADE methodology to assess innovation of new medicinal products in Italy.
25. The impact of parallel regulatory-health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations
26. Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans
27. Managing Risk and Uncertainty in Health Technology Introduction: The Role of Managed Entry Agreements
28. Information needs on precision medicine: a survey of Italian health care professionals.
29. How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
30. Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice
31. Therapeutic indications in oncology: Emerging features and regulatory dynamics
32. Off-label use of medicines in children: can available evidence avoid useless paediatric trials?
33. A new anti-cancer drug in the market: Good news for investors or for patients?
34. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders
35. National and International Differences in the Prices of Branded and Unbranded Medicines
36. Haematological anticancer drugs in Europe: any added value at the time of approval?
37. [Establishing the value of new drugs in Italy.]
38. [Innovative medicinal products: the new criteria of the Italian Medicines Agency.]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.